Tower Research Capital LLC (Trc) Casi Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$1.48 - $2.79 $1,759 - $3,317
1,189 Added 51.58%
3,494 $7,000
Q3 2022

Nov 10, 2022
BUY
$2.36 - $4.69 $585 - $1,163
248 Added 12.06%
2,305 $6,000
Q2 2022

Aug 15, 2022
BUY
$2.85 - $7.1 $5,862 - $14,604
2,057 New
2,057 $6,000

Others Institutions Holding CASI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CASI Pharmaceuticals, Inc.

CASI Quotes by TradingView
  • Ticker CASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,606,100
  • Market Cap $36.5M
  • Description
  • CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patien...
More about CASI
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email